Form 4 Tracker
Flemming Steen Jensen

EVP & Product Supply and Quality · 1 filing · Latest: May 11, 2026

Ascendis Pharma A/S
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ASND
Flemming Steen JensenEVP & Product Supply and QualityMay 11, 2026
Sale
$238.4919,460$4.6M0
ASND
JENSEN FLEMMING STEEN—May 11, 2026
Proposed Sale
$238.4919,460$4.6M—
ASND
JENSEN FLEMMING STEEN—Mar 2, 2026
Proposed Sale
$242.0910,800$2.6M—
ASND
JENSEN FLEMMING STEEN—Dec 2, 2025
Proposed Sale
$205.8510,000$2.1M—
ASND
JENSEN FLEMMING STEEN—Sep 9, 2025
Proposed Sale
$203.705,000$1.0M—
ASND
JENSEN FLEMMING STEEN—Aug 13, 2025
Proposed Sale
$191.3210,000$1.9M—
ASND
JENSEN FLEMMING STEEN—May 7, 2025
Proposed Sale
$162.2010,938$1.8M—
ASND
JENSEN FLEMMING STEEN—Mar 6, 2025
Proposed Sale
$152.3910,000$1.5M—
ASND
JENSEN FLEMMING STEEN—Mar 4, 2025
Proposed Sale
$152.127,719$1.2M—
ASND
JENSEN FLEMMING STEEN—Feb 18, 2025
Proposed Sale
$146.8010,000$1.5M—
ASND
JENSEN FLEMMING STEEN—Dec 10, 2024
Proposed Sale
$129.131,222$157.8K—
ASND
JENSEN FLEMMING STEEN—Dec 3, 2024
Proposed Sale
$131.379,375$1.2M—